Source:http://linkedlifedata.com/resource/pubmed/id/10569618
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-1-6
|
pubmed:abstractText |
We have characterized the androgen receptor (AR) in a new human prostate cancer cell line, MDA PCa 2a, that has recently been established from a bone metastasis of a patient whose cancer exhibited androgen-independent growth.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-5347
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2192-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10569618-Cell Division,
pubmed-meshheading:10569618-Humans,
pubmed-meshheading:10569618-Male,
pubmed-meshheading:10569618-Mutation,
pubmed-meshheading:10569618-Prostate-Specific Antigen,
pubmed-meshheading:10569618-Prostatic Neoplasms,
pubmed-meshheading:10569618-Receptors, Androgen,
pubmed-meshheading:10569618-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.
|
pubmed:affiliation |
Department of Medicine, Stanford University School of Medicine, California, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|